Correction: Cost Effectiveness of Exclusionary EGFR Testing for Taiwanese Patients Newly Diagnosed with Advanced Lung
Huang-Tz Ou1, Jui-Hung Tsai2, Yi-Lin Chen3
1Department of Pharmacy, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Pharmacoeconomics
|December 17, 2025
Abstract
No abstract available in PubMed .
More Related Videos
09:38Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
Published on: August 11, 2017
9.2K
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
1.6K
